Finance
European healthcare stocks hit fresh lows after Trump's tariff threat
Published by Global Banking & Finance Review®
Posted on August 6, 2025
1 min readLast updated: January 22, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on August 6, 2025
1 min readLast updated: January 22, 2026
European healthcare stocks fell after Trump's tariff threat on pharmaceutical imports, with Novartis and Roche among the top decliners.
MILAN (Reuters) -Healthcare stocks led sectoral decliners in Europe on Wednesday, as President Donald Trump's latest threat of higher tariffs on pharmaceutical imports kept traders on edge.
Trump said on Tuesday that Washington would initially impose a "small tariff" before raising it to 150% within 18 months, and eventually to 250%, in a bid to boost domestic production.
The STOXX Healthcare index fell as much as 1.7% by 0933 GMT, hitting its lowest level in over three months and bringing year-to-date losses close to 10%. Among the top fallers were Swiss drugmakers Novartis and Roche.
Shares in weight-loss drugmaker Novo Nordisk struggled to stabilise after last week's rout following a profit warning. The stock was last down over 1.9%.
(Reporting by Danilo Masoni; Editing by Amanda Cooper)
A stock market is a public market for trading company shares and derivatives at an agreed price. It allows investors to buy and sell shares of publicly traded companies.
A profit warning is a statement issued by a company indicating that its profits will be lower than expected. It can affect investor confidence and stock prices.
Explore more articles in the Finance category
